Aotai Biotech announced that the company will implement share repurchases starting February 9, 2026, with an estimated repurchase amount of 1-2 billion yuan. The repurchase of shares will be used to reduce registered capital. As of July 31, the company had repurchased a total of 3,317,500 shares through centralized bidding transactions, accounting for 4.18% of the total share capital. The payment capital was 184 million yuan, and the repurchase price range was 41.88 yuan/share - 68.29 yuan/share. In July, the company repurchased 428,800 shares, accounting for 0.54% of the total share capital, and paid 18.8828 million yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.